Cargando…
Cytomegalovirus Protease Targeted Prodrug Development
[Image: see text] Human cytomegalovirus (HCMV) is a prevalent virus that infects up to 90% of the population. The goal of this research is to determine if small molecular prodrug substrates can be developed for a specific HCMV encoded protease and thus achieve site-specific activation. HCMV encodes...
Autores principales: | Sabit, Hairat, Dahan, Arik, Sun, Jing, Provoda, Chester J., Lee, Kyung-Dall, Hilfinger, John H., Amidon, Gordon L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616455/ https://www.ncbi.nlm.nih.gov/pubmed/23485093 http://dx.doi.org/10.1021/mp3007067 |
Ejemplares similares
-
Enhanced Cancer Cell Growth Inhibition by Dipeptide Prodrugs of Floxuridine: Increased Transporter Affinity and Metabolic Stability
por: Tsume, Yasuhiro, et al.
Publicado: (2008) -
Enhanced Absorption and Growth Inhibition with Amino Acid Monoester Prodrugs of Floxuridine by Targeting hPEPT1 Transporters
por: Tsume, Yasuhiro, et al.
Publicado: (2008) -
An improved synthesis of a fluorophosphonate–polyethylene glycol–biotin probe and its use against competitive substrates
por: Xu, Hao, et al.
Publicado: (2013) -
Dipeptidyl Peptidase IV as a Potential Target for
Selective Prodrug Activation and Chemotherapeutic Action in Cancers
por: Dahan, Arik, et al.
Publicado: (2014) -
Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine
por: Tsume, Yasuhiro, et al.
Publicado: (2017)